Skip to search formSkip to main contentSkip to account menu

Malignant Vipoma

An aggressive neuroendocrine tumor located in the pancreas or small intestine. It is composed of cells containing vasoactive intestinal peptide. It… 
National Institutes of Health

Related topics

Related topics

9 relations
Endocrine systemEpithelial CellsEpitheliumGastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
2014
2014
EXTRA-PANCREATIC VIPOMA
Neuroendocrine tumors of the pancreas are rare neoplasms representing approximately 2% of all pancreatic tumors9. Due to the… 
2009
2009
Diagnosis and Treatment of Pancreatic Vasoactive Intestinal Peptide Endocrine Tumors
Objective: To discuss our experience in diagnosing and treating pancreatic vasoactive intestinal peptide-secreting tumors… 
Review
2008
Review
2008
Metastasierendes Pankreas-VIPom: Diagnostik und Therapie mit dem Somatostatin-Analogon Octreotid
Anamnese: Befunde: Therapie und Verlauf: Folgerung: History: Findings: Treatment and course: Conclusion: 
Review
2005
Review
2005
VIPomas: an update in diagnosis and management in a series of 11 patients.
BACKGROUND/AIMS VIPoma is a rare pancreatic endocrine tumor (PET) which secretes excessive amounts of VIP (Vasoactive Intestinal… 
2000
2000
Somatostatin Receptor Scintigraphy: The Definitive Technique for Characterizing Vasoactive Intestinal Peptide–Secreting Tumors
Vasoactive intestinal peptide–secreting tumors (VIPomas) are extremely rare and difficult to diagnose. The authors describe a… 
2000
2000
Proprotein-processing endoprotease furin and its substrate parathyroid hormone-related protein are coexpressed in insulinoma cells
Parathyroid hormone-related protein (PTHrP) is frequently produced in pancreatic endocrine tumors. PTHrP is synthesized as the… 
Highly Cited
1999
Highly Cited
1999
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms.
PURPOSE To evaluate the prolonged release (PR) of the long-acting somatostatin analog lanreotide in patients with… 
1998
1998
Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
Gastrointestinal neuroendocrine tumors are slowly growing and metastases are often limited to the liver. As a result of their… 
1997
1997
Expression of peptide receptors in human endocrine tumours of the pancreas.
BACKGROUND: Gut peptides are known to influence hormone release and growth of endocrine tumours of the pancreas. Although… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)